Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Sinovac’s COVID-19 vaccine produces antibody response in mid-stage study

Level of antibodies in vaccinated group lower than recovered COVID-19 patients

- PMLiVE

OPEN Health Group Appoints New Leadership

OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A...

OPEN Health

- PMLiVE

The human connection: how to achieve emotive creativity in pharma

By Ian Ray

Roche Basel Switzerland

Roche’s flu pill Xofluza moves closer towards EU approval

CHMP recommends drug for approval in the EU

- PMLiVE

EU secures 405 million doses of CureVac’s COVID-19 vaccine

CureVac revealed early stage data for its vaccine earlier this month

- PMLiVE

J&J advances COVID-19 vaccine into second phase 3 trial

ENSEMBLE study will enrol 60,000 people worldwide

- PMLiVE

Moderna’s COVID-19 vaccine is 94.5% effective, initial data suggests

The UK government has secured access to five million doses of the vaccine

- PMLiVE

Innovation in a digital context is not about technology – it’s about people

By Peter Henshaw

- PMLiVE

Awards or not, what really matters is… can you make it mean something?

By Jon Chapman and Paul Kinsella

- PMLiVE

Synairgen’s SNG001 advances into phase 3 COVID-19 trial

UK biotech had initially been testing drug for COPD and asthma

- PMLiVE

Sobi’s Gamifant receives final rejection from CHMP for primary HLH

Committee reiterated previous negative opinion

- PMLiVE

UCB boosts gene therapy offering with a pair of new deals

Company will collaborate with Lacerta Therapeutics and acquire Handl Therapeutics

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links